Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-02-02 @ 3:50 PM
Study NCT ID:
NCT04526834
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-20
First Post:
2020-08-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma
Sponsor:
Organization: